The cytokinesis-block micronucleus test (MNT), as a marker of chromosomal mutagen sensitivity, was applied in a number of studies enrolling breast cancer (BC) patients and subjects with known or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback